Inauguration of the first Infinix-i 4D CT in Europe

Infinix-i 4DCT

The Montpellier University Hospital (Montpellier, France) has inaugurated an avant-garde interventional radiology intervention room in the Department of Interventional Radiology at the St-Eloi Hospital.

The Infinix-i 4D CT room from Toshiba Medical (acquired by Canon in late 2016) is the first in Europe to combine a new generation angiography room, a 640 slice 4D CT scanner moving on a sophisticated rail concept and a widescreen display. This room is the 11th in the world (Seven in Japan, two in Korea, one in the USA) integrating such advanced technology.

“We are extremely pleased with the new Infinix-i 4D CT system. It is a very flexible and user-friendly system with many intelligent tools for dose optimisation”, said Boris Guiu, head of the Department at St-Eloi Hospital. “With this new room we can carry out complex procedures of hepatic interventional radiology, which require all the existing guidance means, such as liver thermoablations. Each year we approximately take care of 1,000 patients in this room in the best conditions of care, safety and comfort.”

“We are very proud to support the oldest faculty of medicine in Europe with our newest interventional clinical concept”, said René Degros, Business Unit manager X-Ray at Toshiba Medical. “The groundbreaking new Infinix-i 4D CT supports our customers in bridging the gap between the interventional lab and CT with one seamlessly integrated solution for the ultimate in patient care. Infinix-i 4D CT eliminates the need to transfer patients back and forth between different rooms, while minimising dose and maintaining patient safety. In this way the system can help save valuable time and gain efficiencies with the ability to plan, treat, and verify in the same room, on a single system.”

Similar concepts have also been chosen by two other centres in France and will be installed soon, making CHU Montpellier the leader in this field, a press release from the company adds.


Please enter your comment!
Please enter your name here